New ELISA detection kit enables detection and removal of host cell proteins

The ELISA Host Cell Protein (HCP) detection kits from AMSBIO (UK) allow detection of FDA-regulated impurities at any stage of product development.

Go to the profile of AMSBIO
Sep 25, 2019
0
0

A new range of detection kits, based on a sandwich ELISA test, could enable detection of host cell protein (HCP) impurities which could affect therapeutic safety and efficacy. The kits, from AMSBIO (UK), enable the sensitive and accurate determination of HCP concentrations.

FDA has regulated that HCPs should be reduced to low levels. However, host cells used as expression systems in biopharmaceutical products could contain hundreds to thousands of HCPs. Compared to alternative HCP detection kits, AMSBIO offer 5-10x more sensitivity, greater antibody coverage and lower lot-to-lot variations resulting in a more consistent reliable antibody supply and a reduction in the cost of the biomanufacturing process.

Find out more>>

Go to the profile of AMSBIO

AMSBIO

AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development.

No comments yet.